BRIEF-ANI pharmaceuticals paid an aggregate price of $60 mln to buy some of Cranford Pharmaceuticals' assets
* Paid Cranford Pharmaceuticals an aggregate purchase price of $60 million for acquisition of certain assets Source text for Eikon: Further company coverage:
No comments:
Post a Comment